Research

Hormonal

Tirzepatide use is associated with a significantly higher incidence of adverse reactions, particularly nausea and diarrhea, which are dose-dependent and increase with higher doses (15mg).

Be prepared for potential side effects like nausea and diarrhea when starting Tirzepatide. These side effects are more likely at higher doses (15mg) and may decrease over time as your body adjusts. Most people tolerate the medication well, but it's important to discuss these potential side effects with your doctor.

StrongQualifiesHIGH confidence
The total incidence of adverse reactions in Tirzepatide vs control was significantly increased (Odds Ratio (OR): 1.57, 95%CI: 1.35 to 1.81, P<0.000 01), and these adverse reactions were even greater, especially with higher doses and duration of Tirzepatide.
Liya Fu et al. · Clinical Medicine Frontiers · 2026

Why this rating

Based on the same high-quality meta-analysis of 11 RCTs.

Source

Management of Overweight and Obese People with the Dual GIP/GLP-1 Receptor Agonist Tirzepatide: A Systematic Review

Liya Fu et al. · Clinical Medicine Frontiers · 2026

DOI 10.57237/j.cmf.2026.01.001

Meta-analysis · 11 studies
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →